Nintena 150 mg
| SKU | 2639 |
|---|---|
| Generic For | Ofev |
| Manufacturer | Sun Pharmaceuticals Ltd |
| Active Ingredient | Nintedanib |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Capsule/s | US$ 4.86 | US$ 145.80 | |||
|
|||||
| 60 Capsule/s | US$ 4.37 | US$ 262.4410%US$ 291.60 | |||
|
|||||
| 90 Capsule/s | US$ 4.13 | US$ 371.7915%US$ 437.40 | |||
|
|||||
Nintena 150 mg – Affordable Ofev Alternative for Lung Fibrosis
Nintena 150 mg is a prescription treatment for patients with idiopathic pulmonary fibrosis, a lifelong disorder, which causes lung tissues to become thick, making it harder to breathe. The medicine may slow down this lung scarring and help preserve lung function. Nintena contains the active ingredient Nintedanib, a medicine belonging to the class of tyrosine kinase inhibitors.
Besides idiopathic pulmonary fibrosis, there are other conditions in which long tissues become thick and scarred over time and keep worsening. Nintedanib is the active ingredient of the medicine that helps to reduce further scarring and stiffening of the lungs.
What precautions should be taken?
Nintena 150 is unsafe to use during pregnancy and while breastfeeding as there is a risk to the developing baby. However, doctors rarely prescribe it in life-threatening situations and if the benefits outweigh the potential risks. Please consult your doctor for more information. Nintedanib could cause side effects that could affect your ability to drive. Some of you may feel sick after taking medicine, which could affect your driving. The medicine should be used with caution in patients with severe kidney or liver disease. In such cases, dose adjustment may be needed. Consult your doctor for more information. It is not known if consuming alcohol is safe during the treatment. Inform your doctor if you drink alcohol.
What are the side effects of Nintena 150 mg?
Most side effects of Nintedanib 150 mg do not require any medical attention and resolves within a few days as your body adjusts to the medicine. Common side effects include diarrhoea, vomiting, nausea, loss of appetite, weight loss, high blood pressure, weight loss, abdominal pain, and abnormal liver function tests. Talk to your doctor if any of these side effects persist or become bothersome in any way.
How to use Nintena 150 mg?
Take Nintena 150 mg exactly as your doctor has told you. Check with your doctor if you are not sure how much to take and for how long you need to take it. The usual recommended dose is one capsule 150 mg twice daily. Take the capsules twice daily, approximately 12 hours apart every day at about the same time. This ensures that a steady amount of the medicine is maintained in your bloodstream. Swallow capsules whole; do not chew them. It is recommended to take the capsule with food. You should not take more than the recommended dose of Nintena 150 mg per day.
What is Nintedanib and what condition does it treat?
Nintedanib is a tyrosine kinase inhibitor prescribed primarily for idiopathic pulmonary fibrosis (IPF), a chronic lung disease causing progressive scarring of lung tissue. Marketed under brand names like Nintena 150 mg, this antifibrotic medication slows the decline in lung function. It's also used for other forms of progressive fibrosing interstitial lung disease and systemic sclerosis-associated interstitial lung disease. By targeting specific enzymes involved in fibrosis formation, nintedanib helps patients maintain breathing capacity longer and improves quality of life in these debilitating respiratory conditions.
How does Nintedanib work in the body?
Nintedanib works by blocking multiple tyrosine kinase receptors that drive fibrosis development in lung tissue. This antifibrotic agent inhibits growth factors like PDGF, FGF, and VEGF, which normally promote excessive collagen production and scarring. By interfering with these pathways, Nintena 150 mg reduces the formation of scar tissue in the lungs. This mechanism helps preserve lung architecture and slow functional decline in pulmonary fibrosis patients. Unlike anti-inflammatory drugs, this kinase inhibitor directly targets the cellular processes responsible for progressive lung scarring, offering disease-modifying benefits.
How long does Nintena 150 mg take to work?
Nintena 150 mg begins working at the cellular level immediately, but measurable clinical benefits typically emerge over several months. This antifibrotic therapy doesn't reverse existing lung damage; instead, it slows disease progression. Most pulmonary fibrosis patients notice stabilized lung function tests after three to six months of consistent nintedanib treatment. Some experience reduced breathlessness or improved exercise tolerance within this timeframe. Because idiopathic pulmonary fibrosis progresses gradually, the medication's effectiveness is best assessed through periodic pulmonary function testing rather than immediate symptom relief, making patience and adherence crucial.
When and how should I take Nintena 150 mg?
Take Nintena 150 mg twice daily, approximately twelve hours apart, with food to minimize gastrointestinal side effects. Swallow the capsules whole with water—don't chew or open them. Taking this antifibrotic medication with meals significantly reduces nausea and diarrhea, common reactions to nintedanib. Maintain a consistent schedule, ideally with breakfast and dinner. If you miss a dose, skip it if your next scheduled dose is within six hours; never double up. Your doctor may adjust timing based on tolerability and liver function monitoring requirements for this kinase inhibitor therapy.
Is Nintena 150 mg safe for long-term use?
Nintena 150 mg is designed for long-term continuous use in managing chronic pulmonary fibrosis. Clinical trials spanning multiple years demonstrate that nintedanib maintains its safety profile with ongoing treatment, though regular monitoring is essential. Patients on this antifibrotic therapy require periodic liver function tests, as this kinase inhibitor can affect hepatic enzymes. Most individuals tolerate extended treatment well once initial gastrointestinal effects stabilize. Long-term benefits—slowed lung function decline—typically outweigh risks when properly monitored. Duration of therapy continues as long as the medication provides clinical benefit without unacceptable side effects in your idiopathic pulmonary fibrosis management.
Can I take Nintena 150 mg with other medicines?
Nintena 150 mg can interact with certain medications, requiring careful management. This tyrosine kinase inhibitor is affected by strong CYP3A4 inducers like rifampicin and St. John's Wort, which reduce nintedanib effectiveness. Conversely, potent CYP3A4 inhibitors including ketoconazole may increase side effects. Blood thinners like warfarin need monitoring due to bleeding risk. Many pulmonary fibrosis patients safely combine this antifibrotic with bronchodilators, oxygen therapy, and common supplements. Always inform prescribers about all medications, including over-the-counter drugs and herbal products, before starting this kinase inhibitor to prevent dangerous interactions.
How does Nintena 150 mg compare to similar medicines in its class?
Nintena 150 mg contains nintedanib, one of two major antifibrotic agents approved for idiopathic pulmonary fibrosis—the other being pirfenidone. While both slow disease progression, nintedanib offers broader tyrosine kinase inhibition and demonstrates slightly greater preservation of lung function in some studies. This kinase inhibitor typically causes more gastrointestinal effects but fewer photosensitivity reactions than pirfenidone. Neither medication reverses fibrosis, but nintedanib's twice-daily dosing and dual approval for multiple progressive fibrosing lung diseases provide flexibility. Choice between these antifibrotic therapies depends on individual tolerability, comorbidities, and treatment response patterns.
Is the generic Nintedanib as effective as branded versions?
Generic nintedanib contains the identical active ingredient as branded Nintena 150 mg and meets stringent bioequivalence standards, ensuring comparable effectiveness. Regulatory authorities require generics to demonstrate the same absorption, distribution, and therapeutic action as original antifibrotic formulations. The kinase inhibitor molecule works identically regardless of branding. Clinical outcomes for idiopathic pulmonary fibrosis treatment remain consistent between generic and branded versions. Cost differences reflect marketing and development expenses, not efficacy variations. Whether you choose generic nintedanib or branded Nintena, you receive the same disease-modifying benefits for progressive fibrosing lung conditions at different price points.
Why do patients choose PremiumRxDrugs for Nintena 150 mg?
Patients select PremiumRxDrugs for nintedanib therapy because we combine authenticity, affordability, and convenience. Our licensed pharmacy guarantees manufacturer-sourced Nintena 150 mg at competitive pricing—critical for long-term antifibrotic treatment. We've earned trust over more than ten years by delivering genuine kinase inhibitors to customers in the USA, UK, Australia, Canada and worldwide. Easy prescription management and reordering streamline ongoing care for chronic conditions like idiopathic pulmonary fibrosis. Discreet packaging, reliable international shipping with free options, and responsive support make managing your pulmonary medication simpler, letting you focus on health rather than logistics.
What are the common side effects of Nintedanib?
Nintedanib most commonly causes gastrointestinal symptoms including diarrhea, nausea, abdominal pain, and vomiting—affecting approximately 60% of patients initially. Taking this antifibrotic medication with food significantly reduces digestive discomfort. Other frequent reactions include decreased appetite, weight loss, and mild liver enzyme elevations detected through blood tests. Some individuals experience headache or fatigue during treatment. Serious but less common effects include bleeding tendencies and arterial thrombotic events. Most side effects from this tyrosine kinase inhibitor diminish after the first few months as your body adjusts, though diarrhea may persist and sometimes requires anti-diarrheal management.
Who should avoid taking Nintedanib?
Nintedanib is contraindicated for pregnant women due to serious fetal harm risks; effective contraception is mandatory during treatment and afterward. Individuals with moderate-to-severe liver impairment shouldn't use this antifibrotic medication, as the kinase inhibitor is hepatically metabolized and may accumulate dangerously. Those with recent heart attacks or unstable cardiovascular disease require careful evaluation before starting therapy. People with known bleeding disorders or taking anticoagulants need special consideration given increased hemorrhage risk. Breastfeeding mothers should discontinue nursing, as nintedanib passes into milk. Anyone with hypersensitivity to the medication or its components must avoid this tyrosine kinase inhibitor therapy.
Login
Sign Up
Login
Sign Up